Kabra Drugs Ltd
Incorporated in 1989, Kabra Drugs Limited is engaged in the business of Permaculture manufacturing and trading in pharma related products.
- Market Cap ₹ 3.16 Cr.
- Current Price ₹ 7.19
- High / Low ₹ 7.19 / 3.18
- Stock P/E
- Book Value ₹ -2.26
- Dividend Yield 0.00 %
- ROCE -52.7 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5.50 | 10.17 | 11.42 | 8.24 | 9.59 | 7.61 | 1.81 | -0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
4.94 | 9.61 | 10.84 | 7.77 | 9.14 | 7.17 | 2.84 | 0.09 | 0.05 | 0.15 | 0.18 | 0.35 | 0.50 | |
Operating Profit | 0.56 | 0.56 | 0.58 | 0.47 | 0.45 | 0.44 | -1.03 | -0.13 | -0.05 | -0.15 | -0.18 | -0.35 | -0.50 |
OPM % | 10.18% | 5.51% | 5.08% | 5.70% | 4.69% | 5.78% | -56.91% | -150.00% | -3,400.00% | ||||
0.00 | -0.02 | -0.03 | 0.01 | 0.02 | 0.11 | -0.94 | 0.01 | 0.02 | 0.00 | 0.00 | 0.01 | 0.00 | |
Interest | 0.02 | 0.06 | 0.07 | 0.14 | 0.18 | 0.17 | 0.25 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.35 | 0.26 | 0.26 | 0.23 | 0.24 | 0.24 | 0.14 | 0.03 | 0.03 | 0.03 | 0.01 | 0.00 | 0.00 |
Profit before tax | 0.19 | 0.22 | 0.22 | 0.11 | 0.05 | 0.14 | -2.36 | -0.16 | -0.06 | -0.18 | -0.19 | -0.34 | -0.50 |
Tax % | 26.32% | 31.82% | 59.09% | 36.36% | 40.00% | 7.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
0.14 | 0.15 | 0.09 | 0.07 | 0.03 | 0.13 | -2.36 | -0.16 | -0.06 | -0.18 | -0.19 | -0.34 | -0.50 | |
EPS in Rs | 0.32 | 0.34 | 0.21 | 0.16 | 0.07 | 0.30 | -5.38 | -0.36 | -0.14 | -0.41 | -0.43 | -0.77 | -1.14 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | % |
TTM: | -100% |
Stock Price CAGR | |
---|---|
10 Years: | -2% |
5 Years: | 65% |
3 Years: | 22% |
1 Year: | 33% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 |
Reserves | -1.74 | -1.54 | -1.46 | -1.78 | -1.76 | -1.84 | -4.19 | -4.36 | -4.42 | -4.60 | -4.78 | -5.12 | -5.38 |
1.08 | 2.80 | 3.01 | 2.81 | 2.39 | 1.80 | 0.70 | 0.67 | 0.65 | 0.90 | 1.03 | 1.38 | 1.60 | |
2.22 | 3.04 | 3.27 | 3.12 | 4.15 | 2.03 | 0.80 | 0.78 | 0.79 | 0.71 | 0.09 | 0.05 | 0.09 | |
Total Liabilities | 5.95 | 8.69 | 9.21 | 8.54 | 9.17 | 6.38 | 1.70 | 1.48 | 1.41 | 1.40 | 0.73 | 0.70 | 0.70 |
3.99 | 3.51 | 3.30 | 2.78 | 2.73 | 2.48 | 0.11 | 0.08 | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.10 | 0.21 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
1.96 | 5.18 | 5.91 | 5.66 | 6.23 | 3.69 | 1.59 | 1.40 | 1.37 | 1.39 | 0.73 | 0.70 | 0.70 | |
Total Assets | 5.95 | 8.69 | 9.21 | 8.54 | 9.17 | 6.38 | 1.70 | 1.48 | 1.41 | 1.40 | 0.73 | 0.70 | 0.70 |
Cash Flows
Figures in Rs. Crores
Mar 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-1.43 | 0.00 | -0.22 | 0.28 | 0.31 | -0.12 | -0.18 | -0.05 | -0.25 | -0.13 | -0.35 | ||
-0.03 | -0.14 | -0.20 | -0.29 | 0.01 | 1.50 | 0.07 | 0.06 | 0.00 | 0.00 | 0.00 | ||
1.68 | 0.14 | 0.58 | -0.27 | -0.32 | -1.35 | 0.00 | -0.02 | 0.25 | 0.13 | 0.36 | ||
Net Cash Flow | 0.22 | 0.00 | 0.16 | -0.28 | 0.00 | 0.04 | -0.10 | 0.00 | 0.00 | -0.01 | 0.00 |
Ratios
Figures in Rs. Crores
Mar 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 104.19 | 138.89 | 146.38 | 198.00 | 204.00 | 141.49 | 254.09 | -11,406.25 | ||||
Inventory Days | 23.45 | 26.25 | 31.67 | 25.58 | 16.04 | 16.73 | 0.00 | 0.00 | ||||
Days Payable | 207.99 | 98.18 | 79.17 | 129.78 | 139.88 | 97.33 | ||||||
Cash Conversion Cycle | -80.35 | 66.96 | 98.88 | 93.81 | 80.16 | 60.89 | 254.09 | -11,406.25 | ||||
Working Capital Days | -20.57 | 66.76 | 75.43 | 92.58 | 73.46 | 65.23 | 102.85 | 5,018.75 | ||||
ROCE % | 5.57% | 5.52% | 4.40% | 4.41% | 6.62% | -44.19% | -18.75% | -9.09% | -27.48% | -28.57% | -52.71% |
Documents
Announcements
- Regulation 40(9) & 40(10) Of The Securities Exchange Board Of India (LODR) Regulations, 2015, As Amended ('Listing Regulations') 30 Apr
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Apr
- Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR), Regulations 2015 8 Apr
- Closure of Trading Window 31 Mar
- Results-Delay in Financial Results 6 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
-
Financial Year 2006
from bse
Product Profile:[1]
a) Cardiovascular Drugs[2]
b) Anti-infective Drugs[3]
c) Oncology Drugs[4]
d) Gastroenterological Drugs[5]
e) Hormonal Drugs[6]
f) Miscellaneous Drugs[7]
g) Active Pharmaceutical Ingredients[8]